Skip to main content
John Belperio, MD, Pulmonology, Los Angeles, CA

JohnABelperioMD

Pulmonology Los Angeles, CA

Critical Care Medicine, Pleural Disease

Professor, Medicine, UCLA School of Medicine

Dr. Belperio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Belperio's full profile

Already have an account?

  • Office

    UCLA Medical Center
    200 Medical Plaza, Suite 365-B
    Los Angeles, CA 90095
    Phone+1 310-825-8061
    Fax+1 310-825-8061

Education & Training

  • University of Michigan
    University of MichiganFellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 2000
  • University of Maryland
    University of MarylandResidency, Internal Medicine, 1994 - 1997
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2000 - 2025
  • MI State Medical License
    MI State Medical License 1997 - 2000
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Critical Care Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Theravance Biopharma : Announces Top-Line Results from Phase 2 Study of Nezulcitinib in Patients Hospitalized with Acute Lung Injury Due to COVID-19 (Form 8-K)
    Theravance Biopharma : Announces Top-Line Results from Phase 2 Study of Nezulcitinib in Patients Hospitalized with Acute Lung Injury Due to COVID-19 (Form 8-K)June 21st, 2021
  • UCLA Launches Fundraising Effort for New Research Center for Sarcoidosis, Other Advanced Lung Diseases
    UCLA Launches Fundraising Effort for New Research Center for Sarcoidosis, Other Advanced Lung DiseasesNovember 18th, 2019
  • $20 Million Fundraising Effort Will Support Efforts to Improve Treatment for Lung Disease
    $20 Million Fundraising Effort Will Support Efforts to Improve Treatment for Lung DiseaseNovember 14th, 2019
  • Join now to see all

Grant Support

  • The Role Of Chemokines During Lung Allograft DysfunctionNational Heart, Lung, And Blood Institute2005–2009
  • Chemokine Biology In Bronchiolitis Obliterans SyndromeNational Heart, Lung, And Blood Institute2001–2005